MetaCap

C4 Therapeutics Statistics

NASDAQ: CCCCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.48+0.04 (+1.64%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

C4 Therapeutics by the numbers

C4 Therapeutics has a market capitalization of $325.7 million based on 131.32M shares outstanding. With trailing EPS of $-0.63, C4 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.2% below its 50-day average and 24.1% below its 200-day average.

Average daily trading volume is 2.57M shares, or about $6.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CCCC valuation vs. peer median

CCCC compared with the median of 8 peer companies
MetricCCCCPeer medianDifference
Market cap$325.67M$289.71M+12%
Avg. volume2.57M593.54K+334%

Peer median across 8 companies: SLBT, XFOR, TRXB, ALEC, DTIL, AGEN, KYTX, AGMB.

Valuation

Market cap
$325.67M
Price / sales (latest FY)
9.06
EPS (TTM)
$-0.63

Price and trading

Previous close
2.44
Open
2.39
Day range
2.32 – 2.55
52-week range
1.69 – 5.17
52-week change
+1.64%
Beta
—
Volume
3.63M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
325.67M
Forward Pe
-3.01
Eps
-0.63
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.17
Week52 Low
1.69
Avg Volume
2.57M
Shares Outstanding
131.32M
Ma50
3.03
Ma200
3.27
Earnings Date
Nov 5, 2026
Pct From52w High
-52.03%
Pct From52w Low
46.75%

Related